Monovalent Influenza A(H1N1) Vaccine, 1986-1987
Journal: Annals of Internal Medicine (1986)

Diagnosis and Treatment1 November 1986Monovalent Influenza A(H1N1) Vaccine, 1986-1987Recommendations of the Immunization Practices Advisory CommitteeAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-5-737 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractAbstractThese supplemental recommendations provide guidelines for a monovalent influenza A(H1N1) vaccine for protection against a newly emerged variant of influenza that has recently caused outbreaks among children and young adults in Asia. Guidance is provided for the use of this monovalent vaccine, which contains 15 µg of A/Taiwan/1/86(H1N1) antigen, as a supplement to the standard trivalent influenza vaccine. Recommendations for the use of the standard trivalent influenza vaccine for the 1986-1987 season and the use of antivirale for the prevention and treatment of influenza remain in effect and should be referred to in conjunction with this supplemental recommendation. The trivalent vaccine is intended to protect against currently circulating strains of influenza A(H3N2) and influenza B viruses and may provide partial protection against the new influenza A(H1N1) variant.References1. NOBLE G. Epidemiological and clinical aspects of influenza. In: BEARE AS, ed. Basic and Applied Influenza Research. Boca Raton: CRC Press, Inc.: 1982:11-50. Google Scholar2. MONTOKOOPMANLONGINI AJI. Tecumseh study of illness: XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol. 1985;121:811-22. CrossrefGoogle Scholar3. RAYMONDCATONCOXKENDALBROWNLEE FANAG. The antigenicity and evolution of influenza H1 Haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology. 1986;148:275-87. CrossrefGoogle Scholar4. PERROTTADECKERGLEZEN DMW. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol. 1985;122:468-76. CrossrefMedlineGoogle Scholar5. . Prevention and control of influenza. MMWR. 1986;35:317-26, 331. MedlineGoogle Scholar6. . Antigenic variation of recent influenza A(H1N1) viruses. MMWR. 1986;35:510-2. Google Scholar7. . Composition of influenza virus vaccines for the 1986-87 season: an update. Wkly Epidem Rec. 1986;31:237-8. Google Scholar8. LA MONTAGNENOBLEQUINNAN JGG. Summary of clinical trials of inactivated influenza vaccine—1978. Rev Infect Dis. 1983;5:723-36. CrossrefGoogle Scholar9. GROSSQUINNANGAERLAN PGP. Potential for single high-dose influenza immunization in unprimed children. Pediatrics. 1982;70:982-6. Google Scholar10. ARDENPATRIARCALUIHARMONBRANDONKENDAL NPKMFA. Safety and immunogenicity of a 45-µg supplemental dose of inactivated split-virus influenza B vaccine in the elderly [Letter]. J Infect Dis. 1986;153:805-6. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: ▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 November 1986Volume 105, Issue 5Page: 737-739KeywordsElderlySafetyVaccines ePublished: 12 March 2020 Issue Published: 1 November 1986 PDF downloadLoading ...